STRATEGIA HOLDINGS

Strategia Therapeutics offers a fresh approach to drug research and development. We deliver therapeutics faster, more efficiently, and at lower cost to patients than existing R&D models. The problem: inefficiency drives cost The pharmaceutical industry is facing a productivity crisis. In recent years, the costs of drug development have skyrocketed, rising from just over $805 million per product in 2003 to nearly $2.6 billion in 2015. Existing development pipelines suffer from high overhead, sluggish corporate infrastructure, large project teams that lack focus and sometimes specific expertise. Often business decisions do not put patient needs first. As a result, drug success rates are diminishing, while the costs of development continue to rise.

#SimilarOrganizations #People #Website #More